<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1391</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2013</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Eye Lymphoma: a Case Report</title>
	<subject_fa>Pediatric Hematology &amp; Oncology</subject_fa>
	<subject>Pediatric Hematology &amp; Oncology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Non Hodgkin Lymphomas (NHL) are nodal or extra nodal monoclonal infiltrations by malignant lymphoid cells (B
Lymphocytes in 80% of cases), which are distinguished as indolent or aggressive forms.
According to the heterogeneity of lymphoid cells and their ubiquitous anatomical distribution, these disorders can
develop in any organ and have very heterogeneous clinical expressions, but they are usually expressed by tumor
development in the lymphoid tissue (lymph nodes, Waldeyer ring, spleen, bone marrow and sometimes blood).
We report a patient referred to the department of hematology and bone marrow transplantation with an unusual
localization for this type of pathology: eye localized phenotype B lymphoma in its aggressive form, occurring in a 88
years old man.
Clinical remission was obtained by using rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone
protocol combined with radiotherapy.
Keywords: Non Hodgkin lymphoma, aggressive, eye, remission.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Non Hodgkin lymphoma, aggressive, eye, remission.</keyword>
	<start_page>77</start_page>
	<end_page>81</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-1-34&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Abdessamad</first_name>
	<middle_name></middle_name>
	<last_name>Arabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002073</code>
	<orcid>10031947532846002073</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abdelbaki</first_name>
	<middle_name></middle_name>
	<last_name>Boukerche</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002074</code>
	<orcid>10031947532846002074</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohamed</first_name>
	<middle_name></middle_name>
	<last_name>Bey</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002075</code>
	<orcid>10031947532846002075</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Samira</first_name>
	<middle_name></middle_name>
	<last_name>Bouchama</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002076</code>
	<orcid>10031947532846002076</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Lila</first_name>
	<middle_name></middle_name>
	<last_name>Charef</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002077</code>
	<orcid>10031947532846002077</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohamed-Amine</first_name>
	<middle_name></middle_name>
	<last_name>Bekadja</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002078</code>
	<orcid>10031947532846002078</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
